Coala Life has announced expanded functionality of the Coala Heart Monitor allowing for remote lung auscultation using the existing integrated digital stethoscope.
The Coala has recently been made available in the US for home enrolled cardiac monitoring. This added respiratory functionality is made available as a result of FDA’s new emergency guidance striving to help battle COVID-19 during a global health emergency, states the company.
The Coala Heart Monitor is an FDA-cleared and CE Class IIa medical device system intended for remote cardiac and respiratory monitoring. This expanded functionality will enable healthcare providers to use the Coala and its integrated stethoscope to, besides remote cardiac monitoring previously available, remotely auscultate lungs and aid in the detection of pulmonary disease.
The Coala includes an integrated stethoscope, and a synchronous high-resolution 2-lead ECG, allowing for real-time remote diagnostics of arrythmias, forms of congenital heart disease and certain respiratory disorders.